Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01312376
Title Autologous T-Cells Combined With Autologous OC-DC Vaccine in Ovarian Cancer
Recruitment Terminated
Gender female
Phase Phase I
Variant Requirements No
Sponsors Abramson Cancer Center of the University of Pennsylvania
Indications

peritoneal carcinoma

ovarian cancer

fallopian tube cancer

Therapies

Fludarabine

Cyclophosphamide

Bevacizumab

CD3/CD28 stimulated/primed autologous Ts

OC-DC vaccine

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Abramson Cancer Center of the University of Pennsylvania Philadelphia Pennsylvania 19104 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field